| Literature DB >> 32721424 |
Rohan Bir Singh1, Anna Marmalidou1, Afsaneh Amouzegar2, Yihe Chen1, Reza Dana3.
Abstract
Over the past century, corneal transplantation has become the most commonly performed allogeneic solid tissue transplantation. Although more than 80% of the corneal transplantations have favorable outcomes, immune-mediated rejection continues to be the major cause of failure in well over 50% of graft recipients that have inflamed and vascularized host beds. Over the past two decades, the progress in our understanding of the immunological pathways that mediate graft rejection has aided in the development of novel therapeutic strategies. In order to successfully test the efficacy of these interventions, it is essential to model the immunological processes occurring as a consequence of corneal transplantation. Herein, we have comprehensively reviewed the established animal models used for replicating the immunopathological processes causing graft rejection in high-risk corneal transplantation settings. We have also discussed the practical and technical differences, as well as biological and immunological variations in different animal models.Entities:
Keywords: ACAID; Allergic conjunctivitis; High risk corneal transplantation; Penetrating keratoplasty; neovascularization
Year: 2020 PMID: 32721424 PMCID: PMC7508940 DOI: 10.1016/j.exer.2020.108152
Source DB: PubMed Journal: Exp Eye Res ISSN: 0014-4835 Impact factor: 3.467